Korean J Dermatol.
2001 Sep;39(9):1027-1030.
Botulinum Toxin Treatment in a Patient with Frey Syndrome After Upper Thoracic Sympathicotomy
- Affiliations
-
- 1Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea. hceun@snu.ac.kr
- 2Department of National Cancer Center, Seoul National University College of Medicine, Seoul, Korea.
- 3Dream Dermatology, Seoul, Korea.
- 4Laser Center, Seoul, Korea.
Abstract
- Frey syndrome is characterized by profuse facial sweating which is provoked by the taste of food. It has been described as a consequence of upper thoracic sympathicotomy. Botulinum toxin injection is a relatively new treatment modality for Frey syndrome. Botulinum toxin type A (Botox , Allergan, USA) had been successfully used to treat Frey syndrome occurring in a 38-year-old patient following thoracic sympathicotomy for palmar hyperhidrosis. A total dose of 100U of botulinum toxin (1.0U/0.1ml/cm2) injection resulted in a 6 months' resolution of sweating, burning, and flushing sensation on eating. During the follow-up period, no systemic side effects were experienced.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Treatment of Frey's Syndrome Patients with Botulimum Toxin A
- Effectiveness of Botulinum Toxin A in Treatment of Frey's Syndrome
- Botulinum A toxin for the treatment of focal hyperhidrosis: 5 cases
- Botulinum Toxin-Type A in Cervical Myofascial Pain Syndrome: A report of 3 cases
- Application of Botulinum Toxin in Pain Management
